LIFIRAFENIB

UNII:	8762XZS5ZF
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₁₇F₃N₄O₃
Preferred Substance Name:	LIFIRAFENIB
InChIKey:	NGFFVZQXSRKHBM-FKBYEOEOSA-N
GSRS Full Record:	8762XZS5ZF i

1446090-79-4
1,8-NAPHTHYRIDIN-2(1H)-ONE, 5-(((1R,1AS,6BR)-1A,6B-DIHYDRO-1-(6-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOL-2-YL)-1H-CYCLOPROPA(B)BENZOFURAN-5-YL)OXY)-3,4-DIHYDRO-
5-(((1R,1AS,6BR)-1-(6-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOL-2-YL)-1A,6B-DIHYDRO-1H-CYCLOPROPA(B)BENZOFURAN-5-YL)OXY)-3,4-DIHYDRO-1H-1,8-NAPHTHYRIDIN-2-ONE
5-[[(1R,1aS,6bR)-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one
BEIGENE-283
BGB-283
LIFIRAFENIB [USAN]
Lifirafenib [WHO-DD]
lifirafenib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LIFIRAFENIB

Synonyms and Mappings

Resources